FDx Advisors Inc. Has $1.65 Million Holdings in Aetna Inc. (AET)

FDx Advisors Inc. raised its stake in Aetna Inc. (NYSE:AET) by 20.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,371 shares of the company’s stock after buying an additional 1,777 shares during the quarter. FDx Advisors Inc.’s holdings in Aetna were worth $1,649,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of AET. Bruderman Asset Management LLC purchased a new stake in Aetna in the 2nd quarter valued at $106,000. Lloyds Banking Group plc purchased a new stake in Aetna in the 3rd quarter valued at $106,000. Moisand Fitzgerald Tamayo LLC purchased a new stake in Aetna in the 3rd quarter valued at $116,000. Liberty Capital Management Inc. grew its holdings in Aetna by 206.9% in the 2nd quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock valued at $144,000 after buying an additional 629 shares in the last quarter. Finally, Westside Investment Management Inc. grew its holdings in Aetna by 53.5% in the 2nd quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock valued at $177,000 after buying an additional 400 shares in the last quarter. Institutional investors own 90.93% of the company’s stock.

AET has been the subject of several analyst reports. BidaskClub cut Aetna from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 19th. Royal Bank Of Canada upped their target price on Aetna from $162.00 to $171.00 and gave the company an “outperform” rating in a report on Friday, August 4th. Jefferies Group LLC restated a “hold” rating and issued a $163.00 target price (up from $157.00) on shares of Aetna in a report on Friday, August 4th. Deutsche Bank AG upped their target price on Aetna from $157.00 to $163.00 and gave the company a “hold” rating in a report on Monday, August 7th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $175.00 price target (up previously from $150.00) on shares of Aetna in a research note on Wednesday, August 9th. Eleven investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $170.34.

WARNING: “FDx Advisors Inc. Has $1.65 Million Holdings in Aetna Inc. (AET)” was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://sportsperspectives.com/2017/11/14/fdx-advisors-inc-has-1-65-million-holdings-in-aetna-inc-aet.html.

In other Aetna news, EVP Margaret M. Mccarthy sold 10,288 shares of the stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $162.85, for a total value of $1,675,400.80. Following the sale, the executive vice president now owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Karen S. Lynch sold 15,271 shares of the stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the completion of the sale, the president now directly owns 64,261 shares in the company, valued at approximately $10,404,498.51. The disclosure for this sale can be found here. 1.14% of the stock is owned by company insiders.

Shares of Aetna Inc. (NYSE AET) opened at $173.02 on Tuesday. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.53 and a quick ratio of 0.53. The stock has a market capitalization of $57,106.63, a PE ratio of 17.15, a price-to-earnings-growth ratio of 1.60 and a beta of 0.61. Aetna Inc. has a 12-month low of $116.04 and a 12-month high of $184.98.

Aetna (NYSE:AET) last posted its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.06 by $0.39. The company had revenue of $14.99 billion for the quarter, compared to analyst estimates of $15.12 billion. Aetna had a return on equity of 21.84% and a net margin of 2.93%. Aetna’s revenue for the quarter was down 5.0% compared to the same quarter last year. During the same quarter last year, the company earned $2.07 EPS. equities research analysts expect that Aetna Inc. will post 9.78 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Thursday, October 12th were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date was Wednesday, October 11th. Aetna’s dividend payout ratio is currently 37.04%.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply